three-peptide co-lyophilised blend

Glow 70

For research use only

Starting at $130 per vial

$130first month, then $130/mo

Checking availability…

Description

Glow 70 is a co-lyophilised three-component research blend totalling 70 mg per vial: GHK-Cu (copper tripeptide complex, approximately 403.9 Da), BPC-157 (pentadecapeptide, approximately 1419.5 Da) and TB-500 (acetylated thymosin beta-4 fragment Ac-LKKTETQ, approximately 889.0 Da). The three constituents engage separate in vitro pathways — copper-dependent matrix remodelling, VEGFR2-Akt-eNOS signalling and actin-sequestration chemistry respectively. Supplied as a single lyophilised powder. For laboratory research use only.

Batch testedThird-party verifiedLot documented

For research use only

These statements have not been evaluated by the Food and Drug Administration. Supplied strictly for in-vitro laboratory research. Not for human or veterinary use. Nothing on this site is medical advice or a statement about any health outcome. Individual research outcomes vary.

Glow 70 research vial on travertine

Related compounds: GHK-Cu, BPC-157, TB-500

Product information

Glow 70 — co-lyophilised three-peptide research blend, 70mg

Glow 70 is a single lyophilised powder containing three peptide constituents totalling 70 mg per vial: GHK-Cu (glycyl-L-histidyl-L-lysine copper(II) complex, approximately 403.9 Da), BPC-157 (pentadecapeptide, approximately 1419.5 Da) and TB-500 (acetylated thymosin beta-4 fragment Ac-LKKTETQ, approximately 889.0 Da).

Each constituent engages a distinct in-vitro pathway: copper-dependent matrix remodelling, VEGFR2-Akt-eNOS signalling, and actin-sequestration chemistry respectively. The blend is supplied for laboratory research use only.

Constituent chemistry

  • GHK-Cu: copper coordinated through the imidazole nitrogen, deprotonated peptide nitrogen and amino terminus; absorbance maximum near 620 nm.
  • BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, supplied as the acetate salt.
  • TB-500: N-terminally acetylated seven-residue actin-binding fragment of thymosin beta-4.

Form & purity

  • Purity: >99%
  • Form: lyophilized (freeze-dried) powder
  • Grade: for research use only

Lab tested for quality and potency

Every lot is released only after independent third-party testing. Certificates of analysis are available on request.

Purity · Science · Precision · Stability

The same standards on every lot

Third-party tested
>99% purity
Lyophilised
Batch numbered
COA on request
Sealed packaging
"Purity, handling and storage decide whether a result is repeatable. Everything else is downstream of how the vial was made and shipped."
From our handling and storage library

Other compounds in the catalog

Products shown are research peptides supplied for research use and are not evaluated by the FDA. Nothing here is medical advice.

Glow 70

From $130 per vial

  • No long-term contracts
  • Flat price per vial
  • Batch-tested purity
  • Tracked delivery

Checking availability…

Recurring orders can be cancelled any time before the next billing date.

Disclaimer

Research peptides are supplied for research use and are not evaluated by the FDA for safety, effectiveness or quality.

Supplied strictly for in-vitro laboratory research. Not for human or veterinary use. Nothing on this site is medical advice or a statement about any health outcome. Individual research outcomes vary.

Supporting studies

  1. Review of peptide stability and handling in laboratory settings, Journal of Placeholder Chemistry, 2021.
  2. Analytical verification of synthetic peptide identity, Placeholder Research Reports, 2022.
  3. Purity and potency profile of research-grade preparations, Journal of Placeholder Analysis, 2020.
  4. Analytical methods for peptide identity confirmation, Placeholder Research Review, 2023.
  5. Longitudinal review of lyophilised compound stability, Placeholder Research Annals, 2024.